Bicara Therapeutics Highlights Ficerafusp Alfa’s Potential at AACR Annual Meeting
Bicara Therapeutics Inc. made a significant splash at the AACR Annual Meeting, showcasing its promising cancer therapy Ficerafusp Alfa and highlighting its commitment to revolutionizing cancer care.
2 minutes to read